Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness and Safety of Venetoclax in Combination With Azacitidine in Patients With Acute Myeloid Leukemia in Real Life Clinical Practice

NCT05587049 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT05587049
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05587049 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness and Safety of Venetoclax in Combination With Azacitidine in Patients With Acute Myeloid Leukemia in Real Life Clinical Practice
Lead sponsor
AbbVie
Phase
Observational
Overall status
Recruiting
Start date
November 30, 2023
Completion date
November 30, 2026
Enrollment
70 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia